Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017

Amphastar Pharmaceuticals (AMPH) PT Lowered to $20 at Jefferies

May 9, 2017 9:50 AM EDT

Jefferies lowered its price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $20.00 (from $21.00) while maintaining a Buy rating. 1Q EPS of $0.09 was ahead of consensus estimates on lower spending.

Management reported that the FDA recently completed pre-approval inspections for 5 of the 6 ANDAs... More